-+ 0.00%
-+ 0.00%
-+ 0.00%

3 European Growth Stocks With High Insider Ownership And 27% Earnings Growth

Simply Wall St·08/10/2026 05:05:33
Listen to the news

As European markets show resilience with the STOXX Europe 600 Index climbing 1.70% amid firm risk appetite and robust earnings, investors are increasingly interested in growth stocks that demonstrate strong insider ownership. In this context, companies with high insider stakes and impressive earnings growth can be particularly appealing, as they often indicate confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In Europe

Name Insider Ownership Earnings Growth
MilDef Group (OM:MILDEF) 10.3% 30.9%
Kuros Biosciences (SWX:KURN) 25.9% 61.1%
KebNi (OM:KEBNI B) 11.8% 90.9%
Envipco Holding (ENXTAM:ENVI) 15.4% 53.2%
Dellia Group (OB:DELIA) 29.9% 47.9%
CTT Systems (OM:CTT) 17.4% 55.3%
Clavister Holding AB (publ.) (OM:CLAV) 20.5% 73.9%
CD Projekt (WSE:CDR) 35.2% 39%
Bonesupport Holding (OM:BONEX) 10.6% 32.8%
Bergen Carbon Solutions (OB:BCS) 11.9% 50.2%

Click here to see the full list of 220 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Banijay Group (ENXTAM:BNJ)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Banijay Group N.V. operates in content production, distribution, online sports betting, and gaming across the United States, Europe, and internationally with a market cap of €3.84 billion.

Operations: The company's revenue is primarily derived from its Entertainment and Live segment, generating €3.23 billion, and its Sports Betting and Gaming segment, contributing €2.02 billion.

Insider Ownership: 16.3%

Earnings Growth Forecast: 27.1% p.a.

Banijay Group is poised for growth with insider ownership supporting its strategic direction. The recent appointment of Antoine Jouteau as CEO of Banijay Gaming aims to drive expansion and innovation. Despite a dip in net income to €61 million, revenue rose to €2.58 billion for H1 2026, reflecting robust market positioning post-All3Media merger. Forecasted earnings growth of 27% annually outpaces the Dutch market, although interest payments are not fully covered by earnings.

ENXTAM:BNJ Earnings and Revenue Growth as at Aug 2026
ENXTAM:BNJ Earnings and Revenue Growth as at Aug 2026

Universal Music Group (ENXTAM:UMG)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Universal Music Group N.V. operates as a global music company with a market cap of approximately €28.19 billion.

Operations: The company's revenue is primarily derived from Recorded Music (€9.76 billion) and Music Publishing (€2.30 billion), along with Merchandising and Other (€774 million).

Insider Ownership: 18.8%

Earnings Growth Forecast: 27.2% p.a.

Universal Music Group's growth prospects are underpinned by significant insider ownership and strategic initiatives, although revenue growth is slower than the Dutch market. Earnings are forecast to grow significantly at 27.22% annually, outpacing the market average. Recent buybacks totaling €499.19 million highlight commitment to shareholder value despite volatile share prices and a high debt level. The company declared an interim dividend of €432 million, though it remains inadequately covered by earnings, raising sustainability concerns.

ENXTAM:UMG Ownership Breakdown as at Aug 2026
ENXTAM:UMG Ownership Breakdown as at Aug 2026

AlzChem Group (XTRA:ACT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AlzChem Group AG, along with its subsidiaries, develops, produces, and markets a variety of chemical specialties across Germany, the European Union, other parts of Europe, Asia, the NAFTA region, and internationally; it has a market cap of approximately €1.60 billion.

Operations: The company's revenue is primarily derived from its Specialty Chemicals segment, which accounts for €398.39 million, and the Basics & Intermediates segment, contributing €152.20 million.

Insider Ownership: 15.5%

Earnings Growth Forecast: 19.6% p.a.

AlzChem Group's growth is supported by high insider ownership and strategic expansion, including a new U.S. production facility in South Carolina, enhancing its nitroguanidine capacity. Despite slower revenue growth at 11.5% annually compared to the 20% benchmark, earnings are forecast to grow faster than the German market at 19.6%. Recent earnings showed improved performance with Q2 sales of €155.25 million and net income of €16.78 million, reflecting ongoing profitability enhancement efforts.

XTRA:ACT Ownership Breakdown as at Aug 2026
XTRA:ACT Ownership Breakdown as at Aug 2026

Taking Advantage

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.